Anne C. Raimondi proposes multiple ASAN share sales (ASAN)

Rhea-AI Filing Summary

Anne C. Raimondi reported proposed sales of Common stock on Form 144. The filing lists proposed sale entries on 03/16/2026 of 101,366 shares for $711,660.28, on 12/22/2025 of 62,165 shares for $889,556.28, on 12/19/2025 of 76,093 shares for $1,101,106.34, and on 12/18/2025 of 22,198 shares for $322,208.41. The securities are listed as Common and described as restricted stock with an original grant date of 12/20/2024.

Insights

Equity Compliance Analyst

Routine Form 144 notice of proposed dispositions by an insider.

The filing provides transaction dates and per‑entry share counts with associated dollar figures: 101,366 shares ($711,660.28), 62,165 shares ($889,556.28), 76,093 shares ($1,101,106.34), and 22,198 shares ($322,208.41).

These entries represent reported proposed sales under Rule 144 procedures; the excerpt lists the security type as Restricted Stock with grant date 12/20/2024. Cash‑flow treatment and whether sales were executed are not stated in the excerpt; subsequent SEC filings would show consummation or broker reports if applicable.

FAQ

What did Anne C. Raimondi report in the Form 144 for ASAN?

She reported proposed sales of Common stock on Form 144 across four dates totaling multiple entries. The filing lists four entries with share counts of 101,366, 62,165, 76,093, and 22,198 and corresponding dollar figures.

How many shares and proceeds are listed for the 03/16/2026 entry in the Form 144?

The 03/16/2026 entry lists 101,366 Common shares for $711,660.28. This line is presented as a proposed sale entry on the Form 144 excerpt provided.

What security type and original grant date are shown in the filing?

The securities are listed as Restricted Stock with an original grant date of 12/20/2024. That grant date is included in the filing's securities description.

Does this Form 144 confirm the sales were completed?

No—this Form 144 lists proposed or reported sale entries but does not confirm execution. The excerpt provides dates, share counts, and dollar figures but no statement that sales were completed.

Where is the issuer or broker listed for these transactions?

The filing lists Morgan Stanley Smith Barney LLC and an address for Executive Financial Services at 1 New York Plaza. That broker is shown in the filer/issuer information section of the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7630	53632.03	162197788	03/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/20/2024	Restricted Stock	Issuer			7630	12/20/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANNE C RAIMONDI 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	03/16/2026	101366	711660.28
ANNE C RAIMONDI 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	12/22/2025	62165	889556.28
ANNE C RAIMONDI 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	12/19/2025	76093	1101106.34
ANNE C RAIMONDI 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	12/18/2025	22198	322208.41

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)